Identification, characterization, synthesis and HPLC quantification of new process-related impurities and degradation products in retigabine

J Pharm Biomed Anal. 2014 Jun:94:71-6. doi: 10.1016/j.jpba.2014.01.042. Epub 2014 Feb 3.

Abstract

Two new impurities were described and determined using gradient HPLC method with UV detection in retigabine (RET). Using LC-HRMS, NMR and IR analysis the impurities were identified as RET-dimer I: diethyl {4,4'-diamino-6,6'-bis[(4-fluorobenzyl)amino]biphenyl-3,3'-diyl}biscarbamate and RET-dimer II: ethyl {2-amino-5-[{2-amino-4-[(4-fluorobenzyl) amino] phenyl} (ethoxycarbonyl) amino]-4-[(4-fluorobenzyl)amino] phenyl}carbamate. Reference standards of these impurities were synthesized followed by semipreparative HPLC purification. The mechanism of the formation of these impurities is also discussed. An HPLC method was optimized in order to separate, selectively detect and quantify all process-related impurities and degradation products of RET. The presented method, which was validated in terms of linearity, limit of detection (LOD), limit of quantification (LOQ) and selectivity is very quick (less than 11min including re-equilibration time) and therefore highly suitable for routine analysis of RET related substances as well as stability studies.

Keywords: HPLC; Identification; Process-related impurities; Retigabine; Synthesis.

MeSH terms

  • Carbamates / chemistry*
  • Chromatography, High Pressure Liquid / methods
  • Drug Contamination
  • Drug Stability
  • Limit of Detection
  • Phenylenediamines / chemistry*
  • Reference Standards

Substances

  • Carbamates
  • Phenylenediamines
  • ezogabine